stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. MRAI
    stockgist
    HomeTop MoversCompaniesConcepts
    MRAI logo

    Marpai, Inc.

    MRAI
    OTC
    Healthcare
    Medical - Healthcare Plans
    New York City, NY, US117 employeesmarpaihealth.com
    —

    At a Glance

    AI-generated

    Marpai, Inc.

    Revenue breakdown: Third Party Administrator Services (99.8%), Captive Insurance (0.2%).

    8-K
    On March 9, 2026, Marpai, Inc. issued a promissory note in the principal amount of $250,000. The filing discloses this under Item 1.01 Entry into a Material Definitive Agreement and Item 2.03 Creation of a Direct Financial Obligation.

    —

    Market Cap

    —

    Revenue

    —

    Net Income

    Employees117
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Third Party Administrator Services99.8%($46M)
    Captive Insurance0.2%($96.0K)
    Activity

    What Changed Recently

    Management Change
    Jan 22, 2026

    of its Current Reports on Form 8-K filed with the Securities and Exchange Commission on July 21, 2025, August 4, 2025, September 16, 2025, October 6, 2025 and N

    Material Agreement
    Mar 10, 2026

    Entry into a Material Definitive Agreement. On March 9, 2026, Marpai Inc. (the “Company”) issued a promissory note (the “Note”) in the principal amount of $250,

    Material Agreement
    Feb 12, 2026

    Entry into a Material Definitive Agreement. On February 12, 2026, Marpai Inc. (the “Company”) issued a promissory note (the “Note”) in the principal amount of $

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    BBIXFBonus BioGroup Ltd.————
    IPDQFImpediMed Limited————
    AHGIFAlternate Health Corp.————
    CLIFFCordlife Group Limited————
    BMKDFBioMark Diagnostics Inc.————
    CLYYFCelyad Oncology S.A.————
    POSCPositron Corporation————
    CNTMFFluent Corp.————
    Analyst View
    Company Profile
    CIK0001844392
    ISINUS5713542083
    CUSIP571354109
    Phone855 389 7330
    Address401 Park Avenue South, New York City, NY, 10016, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice